Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-10 Hunt Anthony Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −45,351 20,000
2020-08-06 KURIYEL RALF Senior VP, R&D Exercise or conversion +5,000 $33.87 $169K 31,089
2020-08-06 KURIYEL RALF Senior VP, R&D Sale −5,000 $153.79 $769K 26,089
2020-08-06 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −5,000 5,850
2020-07-31 RYAN THOMAS F JR Director Exercise or conversion +2,109 $67.71 $143K 4,559
2020-07-31 RYAN THOMAS F JR Director Sale −2,109 $151.96 $320K 2,450
2020-07-31 RYAN THOMAS F JR Director Sale −986 $151.77 $150K 1,464
2020-07-31 RYAN THOMAS F JR Director Grant or award · Stock Option (Right to Buy) +2,109 0
2020-06-18 DAWES KAREN A Director Sale −2,677 $113.58 $304K 116,762
2020-06-18 DAWES KAREN A Director Sale −5,243 $114.49 $600K 111,519
2020-06-18 DAWES KAREN A Director Sale −8,217 $115.76 $951K 103,302
2020-06-18 DAWES KAREN A Director Sale −2,568 $116.56 $299K 100,734
2020-06-11 EGLINTON MANNER CARRIE Director Grant or award · Stock Option (Right to Buy) +2,794 2,794
2020-05-21 Hunt Anthony Chief Executive Officer Exercise or conversion +7,916 $16.55 $131K 238,157
2020-05-21 Hunt Anthony Chief Executive Officer Exercise or conversion +39,037 $24.98 $975K 277,194
2020-05-21 Hunt Anthony Chief Executive Officer Sale −16,496 $139.17 $2.3M 260,698
2020-05-21 Hunt Anthony Chief Executive Officer Sale −28,980 $140.04 $4.1M 231,718
2020-05-21 Hunt Anthony Chief Executive Officer Sale −1,377 $140.99 $194K 230,341
2020-05-21 Hunt Anthony Chief Executive Officer Sale −100 $141.58 $14K 230,241
2020-05-21 Hunt Anthony Chief Executive Officer Exercise or conversion +3,086 $32.40 $100K 233,327

Page 33 of 42 · 832 trades